(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Virtual Event

2022 年 06 月 15 日 10:00 上午 - 2022 年 06 月 15 日 1:00 下午

(Eastern Standard Time)

R&D QA Comprehensive Quality Strategy: An Approach to Managing Quality Risks throughout the Drug Development Lifecycle

概览

Preregistration required and is an additional fee. Already registered? Log in to DIA's My Account/My Events.
The short course will provide an overview of the development of a cross functional quality strategy framework in an R&D QA organization which, when implemented will proactively identify, manage, and communicate quality risks across the R&D GxP functions throughout drug development lifecycle. Business and operations risks are not addressed in this course. Examples will be workshopped to demonstrate how this methodology can help assure confidence in the quality oversight in preparation for submission to regulatory agencies and for inspections. The value of this approach will be shown, revealing the positive impact on drug development and the potential for enhanced relationships with regulatory agencies.

谁应该参加？

This short course is designed for members involved in Clinical Quality Assurance, R&D Quality Assurance, Clinical operations, Clinical Auditees, and Inspection Management.

学习目标

At the conclusion of this short course, participants should be able to:
  • Describe the risk process
  • Design a strategy to manage risk throughout the drug development lifecycle including establishing Quality Tolerance limits
  • Discuss approaches to implementation of a cross functional quality strategy framework that will proactively identify, manage, and communicate quality risks across the R&D GxP functions throughout drug development lifecycle

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。